APA (7th ed.) Citation

Saito, Y., Murayama, N., Nakano, H., Sato, T., Shimizu, M., Yamazaki, H., . . . Ohyama, K. (2023). Plasma and Hepatic Exposures of Celecoxib and Diclofenac Prescribed Alone in Patients with Cytochrome P450 2C93 Modeled after Virtual Oral Administrations and Likely Associated with Adverse Drug Events Reported in a Japanese Database. Biological & pharmaceutical bulletin, 46(6), 856-863. https://doi.org/10.1248/bpb.b23-00189

Chicago Style (17th ed.) Citation

Saito, Yoshiro, Norie Murayama, Hina Nakano, Tasuku Sato, Makiko Shimizu, Hiroshi Yamazaki, Koichiro Adachi, Yoichi Tanaka, and Katsuhiro Ohyama. "Plasma and Hepatic Exposures of Celecoxib and Diclofenac Prescribed Alone in Patients with Cytochrome P450 2C93 Modeled After Virtual Oral Administrations and Likely Associated with Adverse Drug Events Reported in a Japanese Database." Biological & Pharmaceutical Bulletin 46, no. 6 (2023): 856-863. https://doi.org/10.1248/bpb.b23-00189.

MLA (9th ed.) Citation

Saito, Yoshiro, et al. "Plasma and Hepatic Exposures of Celecoxib and Diclofenac Prescribed Alone in Patients with Cytochrome P450 2C93 Modeled After Virtual Oral Administrations and Likely Associated with Adverse Drug Events Reported in a Japanese Database." Biological & Pharmaceutical Bulletin, vol. 46, no. 6, 2023, pp. 856-863, https://doi.org/10.1248/bpb.b23-00189.